Fintel reports that on October 30, 2025, Citigroup maintained coverage of Bio-Rad Laboratories (NYSE:BIO.B) with a Buy recommendation. Analyst Price Forecast Suggests 21.85% Upside As of April 2, 2025 ...
Upslope Capital Management, an investment management company, released its third-quarter investor letter. A copy of the ...
Bio-Rad Laboratories Inc. (BIO.B) on Wednesday reported a third-quarter loss of $341.9 million, after reporting a profit in the same period a ...
The outlook for full year 2025 remains unchanged at flat to 1% currency-neutral revenue growth, consistent with the Q2 update. Margins guidance is also unchanged. Q3 reported a slight revenue and ...
News-Medical.Net on MSN
Biodesix announces expanded Bio-Rad Laboratories partnership agreement to develop Droplet Digital™ PCR high complexity assays
Biodesix, Inc., a leading diagnostics solutions company, today announced the signing of an expanded partnership agreement ...
Biodesix, Inc. (NYSE: BDSX), a leading diagnostics solutions company, today announced the signing of an expanded partnership agreement under which Biodesix will ...
Nano Banana has been a hit in the Gemini app, and Google is now bringing the model’s (Gemini 2.5 Flash Image) viral image editing and generation to AI Mode, as well as Google Lens. On Android, there’s ...
The TC20 automated cell counter counts mammalian cells in one simple step using its innovative auto-focus technology and sophisticated cell counting algorithm to produce accurate cell counts in less ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback